Navigation Links
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
Date:5/13/2009

DURHAM, N.C., May 13 /PRNewswire/ -- Addrenex Pharmaceuticals today expanded its pipeline of products aimed at adrenergic regulation with the signing of an agreement to license a new drug for the treatment of narcolepsy, a chronic and debilitating sleep disorder, as well as other neurologic and psychiatric conditions.

The agreement to license ADX-N05 gives Addrenex the worldwide rights (excluding East Asia) to develop, manufacture and commercialize the compound from SK Life Science Business Division, the drug-discovery and development division of SK Holdings Co. Ltd., one of the largest multinational companies based in South Korea.

"The partnership with SK Holdings embodies our commitment to seeking global alliances that further our goal of developing drugs for adrenergic regulation," said Steve Butts, Vice President of Commercial Operations for Addrenex Pharmaceuticals.

"We are pleased and excited to partner with an innovative, dynamic company such as SK Holdings, and we expect this to be the first of many global development partnerships for Addrenex," he added.

The licensing deal with SK Holdings provides Addrenex with its fourth drug candidate to enter clinical trials in three years. Each of Addrenex's drugs in development focuses on the treatment of medical conditions arising from an overactive or improperly regulated adrenergic system, a group of hormones and brain chemical messengers known as neurotransmitters. These hormones and neurotransmitters regulate diverse physiologic functions such as stress, pain, sleep and blood pressure.

Addrenex's lead products are Clonicel(R) for the treatment of attention-deficit hyperactivity disorder (ADHD) and Sympres(R) for the treatment of hypertension. The company also plans to develop drugs to treat menopausal flushing and potentially pain, insomnia and migraines, all of which are impacted by the adrenergic system.

'/>"/>

SOURCE Addrenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication
2. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
3. Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
4. Addrenex Pharmaceuticals New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
5. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
6. ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting
7. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
8. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting
9. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
10. Transcept Pharmaceuticals to Report First Quarter 2009 Results
11. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... LONDON , July 31, 2014 ... the medical industries, announced today the incorporation of genae UK in ... Kingdom has one of the largest medical device markets ... 2012 and it is projected to increase by a CAGR of ... in 2012, equal to 9.5% of GDP. Despite recessionary pressures, market ...
(Date:7/31/2014)... YORK , July 31, 2014 ... discovering and developing better, faster and affordable treatments, ... as Senior Vice President, External Affairs. Mr. Brock ... as Head of Major Donor Relations for WWF ... In his role, Mr. Brock will guide the ...
(Date:7/31/2014)... , July 31, 2014  Genomic Health, Inc. (Nasdaq: ... host a conference call and webcast on Thursday, August 7 ... 2014 financial results.  The call and webcast will follow the ... Conference Call Details To access the live conference ... phone, please dial (877) 303-7208 from the United ...
Breaking Medicine Technology:genae Opens Offices in London 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 3Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 4
... 27, 2012   VWR International, LLC , a global ... that it has signed an agreement to acquire ... in The Netherlands, France, Italy, Singapore, Malaysia and Vietnam. ... regulatory approval in Germany. With 30 years ...
... 2012  MetaStat, Inc. (OTCBB: MTST) announced today that ... patent applications and technology from the Albert Einstein ... license agreement covers U.S. Patent Application No. 12/998,237 ... Anti-Metastasis Treatment Efficacy"; inventors: Jeffrey Edward Segall, John ...
Cached Medicine Technology:VWR International, LLC Signs Agreement to Acquire basan Germany GmbH 2MetaStat, Inc. Executes Two New Licenses 2MetaStat, Inc. Executes Two New Licenses 3
(Date:7/31/2014)... Zensah®, a leading Miami based compression apparel company, ... , designed to help target tennis elbow, elbow tendonitis, ... for summer. The compression elbow sleeve is now available ... Zensah® fabric, the elbow sleeve is made ... no-slip cuff to ensure it stays in place, even ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 To further ... like to provide the following safety information regarding leaving ... a car can have deadly consequences. Because a child’s ... than those of adults, leaving children alone in a ... injury, and even death. , Statistics of Children Left ...
(Date:7/31/2014)... Most mommy blogs are simple family ... is to attract all mothers from all walks of ... group; whether its high fashion or child rearing. When ... on the Internet was so segmented. “I found myself ... topic and then search Google to get information on ...
(Date:7/31/2014)... A chance meeting at last April’s ASCAP “I ... Jimmy Robbins to Etymotic Research and their hearing ... in hearing wellness solutions, and maker of Music•PRO® ... Music•PRO® Electronic Earplugs have revolutionized hearing protection by ... natural hearing when hearing is not at risk. ...
(Date:7/31/2014)... News) -- Transplant surgeons often feel emotionally drained ... a new study suggests. Nearly half of ... a low sense of personal accomplishment and four ... researchers found. "Burnout is common in medicine, ... Dr. Marwan Abouljoud, director of the Henry Ford ...
Breaking Medicine News(10 mins):Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 2Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 3Health News:The Rothenberg Law Firm LLP Teams Up with Local Philadelphia TV Stations to Promote Awareness of the Dangers of Leaving Children Unattended in a Hot Vehicle 2Health News:The Rothenberg Law Firm LLP Teams Up with Local Philadelphia TV Stations to Promote Awareness of the Dangers of Leaving Children Unattended in a Hot Vehicle 3Health News:Mommylish Launches Its Website 2Health News:Country Star Jimmy Robbins Now Using Etymotic’s MusicPRO Electronic Earplugs 2Health News:Burnout Common Among Transplant Surgeons, Study Reveals 2
... measurements into account , TUESDAY, Sept. 1 (HealthDay News) -- ... & World Report list of best hospitals for heart ... failure, researchers say. , "If you really want to know ... mortality and readmission, you should look directly at government statistics ...
... flu strains , TUESDAY, Sept. 1 (HealthDay News) -- Fears ... this year may be unfounded, say researchers at the University ... the swine flu pandemic did not take a virulent turn ... did spread more rapidly than the other viruses, confirming the ...
... , , ... Board: MLSS), the recognized leader in advanced injection technologies, today ... Chairman of the Board, succeeding Leonard Osser who had previously ... has also served as the interim Chief Executive Officer since ...
... , WARSAW, Ind., Sept. 1 Zimmer Holdings, Inc. (NYSE: ... following investor conferences during the month of September: , , ... Mass., on September 9, 2009, at 11:30 a.m. Eastern Time; , ... September 14, 2009, at 8:35 a.m. Eastern Time; and , ...
... , CARDIFF, Calif., Sept. 1 ... http://www.jedimindinc.com ) announced today that their Medical Division is ... in wheelchairs. An estimated 1.6 million Americans residing outside of ... Interview Survey on Disability (NHIS-D). Jedi Mind,s Medical Division is ...
... , ... Information Association (DIA) will host Personalized Medicine: Biomarkers and Diagnostics in Drug Development, Regulatory ... , ... September 1, 2009 -- The Drug Information Association (DIA) will host ...
Cached Medicine News:Health News:Government Best Source for U.S. Hospital Data, Study Finds 2Health News:Swine Flu May Be Less Dangerous Than Predicted: Study 2Health News:Swine Flu May Be Less Dangerous Than Predicted: Study 3Health News:Milestone Scientific Announces Key Leadership Changes 2Health News:Milestone Scientific Announces Key Leadership Changes 3Health News:Jedi Mind Medical Applications Division to Concentrate on Wheelchair Mobility Applications 2Health News:DIA Conference to Explore The Science and Scope of Personalized Medicine 2
... The Leica RM2235 is a robust ... of primarily biological specimens embedded in ... backlash-free precision micrometer feed system ensures ... even when sectioning harder tissues. The ...
... biomedical and industrial applications, the Leica SM2400 ... of applications in all laboratories where paraffin ... sectioned. Its sturdy construction lends it qualities ... features of the system, such as a ...
... Automatic microtome with vibrating blade for fixed and ... as for non-biological specimen in material science ... of blade amplitude between 0,1 and 1,2 mm ... parameters can be set independently from each other. ...
... EC 350 consists of two modular units. ... surface and reaches a temperature of -15C. ... reservoir, heated dispenser nozzle, heated work surface, ... separate heated compartments for molds and cassettes. ...
Medicine Products: